Quincy Okobi is a graduate student in the Molecular Biology interdepartmental Ph. D program at UCLA. He completed his undergraduate degree at UC Santa Cruz in Molecular, Cell and Developmental Biology where he worked under Dr. Doug Kellogg studying cell growth and cell size. During the following two years he worked at Somagenics where his project focused on developing miRNA detection technologies through library preparation and sequencing platforms such as Illumina. He is currently studying the molecular mechanisms underlying acquired resistance to EGFR-targeted therapy in glioblastoma (GBM), while the goal of identifying new strategies to overcome drug resistance.